Further analysis illuminated correlations between higher anoikis scores and more advanced tumor (T) staging, higher Gleason scores (GS), and increased likelihood of BCR, implicating this gene signature as a marker of aggressive disease (Figure 4A). This evidence concerns the gene BCR and neoplasm.